Surrozen to present at H.C. Wainwright Ophthalmology Conference on July 22, 2026
Surrozen, a biotech company specializing in eye disease therapies, will present at the H.C. Wainwright 6th Annual Ophthalmology Virtual Conference on July 22, 2026. The presentation will feature a fireside chat on their Wnt signaling-based therapeutics for sight-threatening ophthalmic conditions. This event underscores Surrozen's …